Steroid Sparing Regimen With Olanzapine and Palonosetron for Emetic Prevention for High Dose Cisplatin
Trial statusRecruiting
Trial phasePhase 2
Trial typeInterventional
Biological sexAll
Age18+
SponsorMahidol University
About this trial
A phase II study evaluating dexamethasone sparing regimen with olanzapine and palonosetron for patients receiving high dose cisplatin to prevent chemotherapy induced nausea and vomiting
Eligibility criteria
Qualifiers
histologically confirmed solid malignancy
scheduled for first cycle of cisplatin at dosage of at least 50 mg/m2
Disqualifiers
pregnancy
pelvic or abdominal radiation within 4 weeks
uncontrolled brain metastasis
other moderate or high emetic risk chemotherapy on day 2-5
Trial design
Treatments tested in this trial
- dexamethasone sparing
Treatment groups
95 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov